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Background: It is generally recognised that continuous quality improvement (CQI) programs support development
of high quality primary health care systems. However, there is limited evidence demonstrating their system-wide
effectiveness. We examined variation in quality of Type 2 diabetes service delivery in over 100 Aboriginal and Torres
Strait Islander primary health care centres participating in a wide-scale CQI project over the past decade, and
determined the influence of health centre and patient level factors on quality of care, with specific attention to
health centre duration of participation in a CQI program.
Methods: We analysed over 10,000 clinical audit records to assess quality of Type 2 diabetes care of patients in 132
Aboriginal and Torres Strait Islander community health centres in five states/territories participating in the ABCD
project for varying periods between 2005 and 2012. Process indicators of quality of care for each patient were
calculated by determining the proportion of recommended guideline scheduled services that were documented as
delivered. Multilevel regression models were used to quantify the amount of variation in Type 2 diabetes service
delivery attributable to health centre or patient level factors and to identify those factors associated with greater
adherence to best practice guidelines.
Results: Health centre factors that were independently associated with adherence to best practice guidelines
included longer participation in the CQI program, remoteness of health centres, and regularity of client attendance.
Significantly associated patient level variables included greater age, and number of co-morbidities and disease
complications. Health centre factors explained 37% of the differences in level of service delivery between jurisdictions
with patient factors explaining only a further 1%.
Conclusions: At the health centre level, Type 2 diabetes service delivery could be improved through long term
commitment to CQI, encouraging regular attendance (for example, through patient reminder systems) and improved
recording and coordination of patient care in the complex service provider environments that are characteristic of
non-remote areas.
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Table 1 Health centre participation in Type 2 diabetes










n (%) n (%) n (%)
2006 2 (5) 11 (27) 28 (68) 41
2007 2 (20) 3 (30) 5 (50) 10
2008 1 (11) 3 (33) 5 (56) 9
2009 0 (0) 2 (22) 7 (78) 9
2010 3 (25) 9 (75) 12
2011 13 (33) 27 (68) 40
2012 11 (100) 11
Total 32 (24) 55 (42) 45 (34) 132
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The international diabetes epidemic is expected to escal-
ate over coming decades placing increasing economic
and social pressures on health systems and communities
[1-3]. In addition, socio-economic and ethnic inequities
have been identified in provision of diabetes care [4]. So-
cial determinants and lack of access to quality primary
health care (PHC) services are important contributors to
the inequity in health outcomes between Aboriginal and
Torres Strait Islander communities and the Australian
non-Indigenous population. Over the past decade, there
has been a significant increase in prevalence of diabetes
in the Aboriginal and Torres Strait Islander population
and they are now three times more likely to have dia-
betes compared to the non-Indigenous Australian popu-
lation [5].
Along with targeted prevention strategies, improve-
ments in chronic disease care are necessary to reduce in-
equity, advance population health outcomes and lessen
the burden on health care systems. Evidence indicates
that improvements in quality of care and health out-
comes can be achieved using integrated care frameworks
and multifaceted improvement strategies targeting changes
at all levels of the health system [6-9]. However, the effect-
iveness of local and large scale quality improvement ap-
proaches in health care remains uncertain with published
studies showing considerable variation in levels of im-
provements achieved [10,11].
Australian Aboriginal and Torres Strait Islander primary
health care setting
There are a number of service sectors providing primary
health care to Aboriginal and Torres Strait Islander
communities. In recognition of the need for culturally
appropriate care, Aboriginal and Torres Strait Islander
community-controlled health services were developed
over 40 years ago, employing a comprehensive care
model with local Aboriginal and Torres Strait Islander
participation and control in guiding, planning and delivery
of services. The success of the community-controlled sec-
tor has led other health care providers to adopt commu-
nity participatory processes in health service design,
including a State and Territory government operated com-
munity health centre predominantly servicing an Indigen-
ous community [12]. Both of these sectors are represented
in metropolitan, remote and very remote locations across
Australia.
One21seventy/ABCD CQI program
Over the past decade, a wide scale continuous quality im-
provement (CQI) program operating in both Aboriginal
and Torres Strait Islander community controlled and gov-
ernment centres has included a focus on Type 2 diabetes.
The Audit and Best Practice for Chronic Disease (ABCD)project employs a systems approach to improving PHC
delivery utilising evidence-based clinical audit and system
assessment tools to enable health centres to assess and re-
flect on system performance [13,14]. Typically, health cen-
tres conduct audits on an annual basis choosing from a
suite of tools covering various aspects of PHC (including
Type 2 diabetes, chronic kidney disease, coronary heart
disease, maternal and child health, preventive health and
mental health). A not-for-profit service agency, One21-
seventy, develops and maintains evidence-based audit and
systems assessment tools, provides online data services for
automated reporting, benchmarking and interpretation,
and training and site support for conducting audits ac-
cording to standard protocols. Over 100 health centres
using the One21seventy/ABCD tools have voluntarily pro-
vided their de-identified audit data to the ABCD National
Research Partnership for analysis of variation in PHC ser-
vice delivery.
The aim of this study is to examine trends in the qual-
ity of Type 2 diabetes processes of care over time for
participating health centres and identify the influence of
regional, health centre, and individual patient level fac-
tors on delivery of services scheduled in current guide-
lines. Specifically, the analysis aimed to explore whether
or not health centre duration of participation in the
ABCD CQI program was associated with improvements
in Type 2 diabetes service delivery.
Methods
Study context and design
Table 1 shows completion rates of Type 2 diabetes au-
dits by year of commencement in the project. Coinciding
with stepped phases of research and geographical exten-
sions of the project, a large number of health centres
joined the program in 2006 (n = 41) and 2011 (n = 40).
Participation in annual Type 2 diabetes audits is driven
by health centre decision processes based on local prior-
ities. As such, not all health centres completed Type 2
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may have focussed on other clinical areas in-between
diabetes audit cycles. This retrospective longitudinal study
used Type 2 diabetes audit data to examine changes in
quality of care over time and explore factors underlying
variation in care delivery.
Data collection
Clinical audit records from 132 Aboriginal and Torres
Strait Islander community health centres in five states/
territories participating in the ABCD project between
2005 and 2012 were analysed to assess quality of Type 2
diabetes care of patients. Clinical audits are generally
completed by health centre staff trained in the use of
One21seventy/ABCD tools and supported by quality im-
provement facilitators and/or One21seventy staff. The
Type 2 diabetes audit tool was developed by an expert
working group, with participation of chronic illness ex-
perts and health service staff from a number of jurisdic-
tions across Australia. The tool is designed to enable
services to assess their actual practice against best prac-
tice standards, and is accompanied by a protocol that in-
cludes reference to the guidelines that form the basis of
the tool. Inter-rater validation tests were carried out as
part of pilot testing. One21seventy/ABCD tools and pro-
tocols are regularly reviewed by expert reference groups
to ensure continued alignment with best practice stan-
dards. Audit data are collected manually by health cen-
tres and directly entered into the One21seventy online
database system.
The criteria for inclusion in a Type 2 diabetes audit in-
cludes patients who: have a diagnosis of Type 2 diabetes;
are aged 16 years or older; and have lived within com-
munity for six months or more in the last year. Where
the eligible population is 30 or less, the audit protocol
recommends that all eligible records at that health
centre are audited. For 30 or more eligible clients, the
protocol recommends and provides guidance for health
centres to draw a sufficient number of records to achieve
a precision of 90% or 95% confidence of the sample repre-
senting the population [15]. This sampling approach re-
sulted in a total sample of 10,674 records available for
analysis in this study.
Ethics approval was obtained from research ethics
committees in each jurisdiction (Human Research Ethics
Committee of the Northern Territory Department of
Health and Menzies School of Health Research (HREC-
EC00153); Central Australian Human Research Ethics
Committee (HREC-12-53); New South Wales Greater
Western Area Health Service Human Research Committee
(HREC/11/GWAHS/23); Queensland Human Research
Ethics Committee Darling Downs Health Services District
(HREC/11/QTDD/47); South Australian Aboriginal Health
Research Ethics Committee (04-10-319); Curtin UniversityHuman Research Ethics Committee (HR140/2008); West-
ern Australian Country Health Services Research Ethics
Committee (2011/27); Western Australia Aboriginal Health
Information and Ethics Committee (111-8/05); University
of Western Australia Human Research Ethics Committee
(RA/4/1/5051)).
Data analysis
To assess Type 2 diabetes service delivery, the study
measured 15 items from best practice guidelines used
across the states and territories. The service items in-
cluded laboratory investigations (albumin creatinine ra-
tio, estimated glomerular filtration rate, full lipid profile
and glycosylated haemoglobin), physical checks (weight,
waist circumference, body mass index, blood pressure,
visual acuity, dilated eye check, foot check) and counsel-
ling for certain risk factors (nutrition, physical activity,
tobacco and alcohol use). Process of care performance
for each patient was calculated by determining the pro-
portion of services received out of the 15 scheduled ser-
vices. A mean adherence to delivery of Type 2 diabetes
services in a given health centre represented an overall
performance score for the health centre in a given audit
cycle. Each aggregate score was converted into a binary
outcome variable that categorised ‘higher’ performance
as being within the top quartile of delivery across all
health centres measured at baseline (greater than 76%
service delivery). Health centre characteristics included
length of participation in ABCD CQI, regularity of client
attendance, size of service population, governance (com-
munity-controlled or government operated) and location
based on the Australian Standard Geographical Classifi-
cation (AGSC) system (very remote, remote or non-
remote). For statistical analysis, rates of patient attend-
ance were calculated based on the proportion of patients
that did not attend in the previous six months prior to
audit. A binary outcome variable was created that cate-
gorised a health centre as having ‘lower regular attend-
ance’ if more than 3% of patients did not attend within
the previous six months.
Patient level characteristics (sex, age, Indigenous sta-
tus) were extracted from clinical records. Documented
chronic health conditions (diabetes, hypertension, chronic
heart disease and chronic kidney disease) were recorded
as present or absent and co-morbidities were calculated
by summing the recorded presence of each condition.
Similarly, documented complications (retinopathy, neur-
opathy, foot ulcers and amputations) were recorded as
present or absent and number of complications was calcu-
lated per individual.
Multilevel mixed effects logistic regression models
were used to quantify the variation in Type 2 diabetes
service delivery attributable to health centre or patient
level factors, allowing for the hierarchical structure of
Matthews et al. BMC Health Services Research 2014, 14:578 Page 4 of 12
http://www.biomedcentral.com/1472-6963/14/578the data (patients nested within health centres nested
within jurisdictions). Crude odds ratios were calculated
to measure the unadjusted association between the out-
come and predictor variables. Non-significant variables
were excluded from further analysis. Potential interac-
tions were checked for significance. We adopted a step-
wise modelling strategy starting with Model A that
included the audit year variable only to test the influence
of jurisdictions and health centres on Type 2 diabetes
processes over time. Significant health centre (Model B)
and then patient level variables (Model C) from the un-
adjusted analysis were introduced into the empty model.
Predicted means and 95% confidence intervals were ob-
tained from the regression analyses to rank jurisdictions
and health centres according to their probability of pro-
viding a higher proportion of services compared to the
overall mean probability (log odds scale).
The reduction in variance due to the stepwise intro-
duction of the different variables in the models was de-
termined by the proportional change in variance (PCV)
at different levels. The PCV provides an estimate of the
extent to which health centre or patient level factorsTable 2 Characteristics of health centres and patients with Ty
Far W
South
Total number health centres 6





Service Population ≤500 2 (33)
501-999 1 (17)
≥1000 3 (50)
Mean % (and range) clients that did not attend in last 6 months 21 (3–
Duration of participation in ABCD CQI <1 year 0
1-2 years 0
>3 years 6 (100
Number of patient records audited 936
Age (years) mean & (range) 57 (19
Gender Male 441 (4
Female 495 (5
Indigenous status Indigenous 514 (5
Non-indigenous 384 (4
Not recorded 38 (4)
Two or more co-morbidities 770 (8
Complications No complications 781 (8
1-2 complications 148 (1
>2 complications 7 (1)may explain individual differences in propensity for bet-
ter health care delivery [16]. Median odds ratios (MORs)
were calculated to help interpret variance in the odds ra-
tio scale. The MOR is the increased (median) probability
of receiving ‘a high proportion of ’ recommended care
processes if a patient was to change health centre or jur-
isdiction [16,17]. If the MOR was equal to 1, there would
be no difference between jurisdictions/health centres. If
there were important differences between jurisdictions/
health centres, the MOR would be large. The accuracy
of the variance estimates was evaluated by their stand-
ard error (SE). A p-value ≥0.05 was considered non-
significant. Statistical analyses were conducted with STATA
software, V.13.
Results
Of the 132 participating health centres, 79% were lo-
cated in very remote or remote areas, 44% had a service
population of 500 or fewer, and 73% were government
operated (Table 2). In all jurisdictions, on average, ap-
proximately 90% of clients audited attended the health










62 44 6 14 132
51 (82) 29 (66) 2 (33) 5 (36) 89 (67)
9 (15) 4 (9) 0 2 (14) 16 (12)
2 (3) 11 (25) 4 (67) 7 (50) 27 (20)
44 (71) 44 (100) 3 (50) 6 (43) 97 (73)
) 18 (29) 0 3 (50) 8 (57) 35 (27)
35 (56) 18 (41) 1 (17) 2 (14) 58 (44)
12 (19) 11 (25) 2 (33) 0 26 (20)
15 (24) 15 (34) 3 (50) 12 (86) 48 (36)
47) 4 (0–22) 12 (0–45) 25 (12–49) 17 (0–50) 10 (0–50)
14 (23) 12 (27) 2 (33) 4 (29) 32 (24)
26 (42) 19 (43) 4 (67) 6 (43) 55 (42)
) 22 (35) 13 (30) 0 4 (29) 45 (34)
4849 3407 333 1149 10674
–94) 50 (15–91) 54 (15–97) 52 (16–86) 52 (17–88) 52 (15–97)
7) 1925 (40) 1587 (47) 136 (41) 472 (41) 4561 (43)
3) 2924 (60) 1820 (53) 197 (59) 677 (59) 6113 (57)
5) 4684 (97) 2347 (69) 313 (94) 1071 (93) 8929 (84)
1) 127 (3) 591 (17) 20 (6) 56 (5) 1178 (11)
38 (1) 469 (14) 0 22 (2) 567 (5)
2) 3570 (74) 2326 (68) 210 (63) 677 (59) 7553 (71)
3) 4185 (86) 2832 (83) 302 (91) 1000 (87) 9100 (85)
6) 613 (13) 510 (15) 27 (8) 134 (12) 1432 (13)
51 (1) 65 (2) 4 (1) 15 (1) 142 (1)
Table 3 Percentage of clients that did not attend the




Percent clients that did not attend in the last
six months
Location Mean SE Min Max
Non-remote 27 25 2.76 2 50
Remote 16 11 2.30 3 36
Very Remote 89 5 0.60 0 27
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within the previous six months in non-remote areas
(25%) compared to remote (11%) and very remote areas
(5%; Table 3). The mean age of patients was 52 years
and 57% were female. Over 90% of records from the
Northern Territory, Western Australia and South Australia
were for Aboriginal or Torres Strait Islander people, com-
pared to 69% in Queensland and 55% in Far West New
South Wales health centres. Around 71% of patients had
co-morbidities and 14% had one or more diabetes compli-
cations. These occurred more commonly in older patients
(Table 4).
Of all health services participating in the study around
one third (34%) completed three or more cycles, 42%
completed one to two cycles and 24% completed base-
line audit only. This does not reflect attrition of health
services, as some services commenced participation at
differing time periods (Table 5). Of those health centres
only completing baseline audits, 75% commenced ABCD
CQI participation in 2011 or 2012 (Table 1).
The distribution of remoteness of centres did not dif-
fer markedly by duration of participation in CQI, for ex-
ample, 66%, 62% and 76% of health centres completing
baseline, 1–2 audit cycles and 3 or more audit cycles re-
spectively were from very remote areas. The distribution
of health centres by governance showed that 47% of
health centres that completed 3 or more cycles were
community-controlled organisations and there was also
an equal distribution of health centres by service popula-
tion size that completed 3 or more cycles (Table 5).
Wide variation in delivery of Type 2 diabetes services
was evident across all health centres within an audit yearTable 4 Clients with co-morbidities and disease complication
Number of chronic conditions documented
Age
(years)
One condition ≥2 conditions
n (%) n (%)
15 to <25 115 (65) 63 (35)
25 to <40 716 (39) 1114 (61)
40 to <55 1246 (29) 3035 (70)
> = 55 1044 (24) 3341 (76)
Total 3121 (29) 7553 (71)and over time (Figure 1a). However, for those health
centres that completed at least three audit cycles (n = 45)
there was a trend of decreasing variation across successive
cycles of CQI (Figure 1b). There were large improvements
in service delivery in lower performing health centres from
less than 20% in early cycles to 40-50% in later cycles
(Figure 1b).
In explaining this variation, the unadjusted logistic re-
gression analysis showed that duration of participation in
the ABCD CQI program, remoteness, regularity of patient
attendance, patient age, level of co-morbidity and number
of disease complications, were significantly associated
with improved Type 2 diabetes service delivery (Table 6).
Remoteness of health centres showed the strongest associ-
ation with very remote and remote centres having 4.57
(95% CI 2.61-8.01) and 2.55 (95% CI 1.22-5.35) times the
odds of being in the top quartile of Type 2 diabetes ser-
vice delivery compared to non-remote centres. We tested
the interaction between remoteness and duration of CQI
participation and found significant improvement in ser-
vice delivery with length of participation irrespective of
health centre location. There was, however, a gradient of
increasing odds of improvement from non-remote, to re-
mote and very remote centres. The odds of receiving top
quartile service delivery also increased with increasing
age, co-morbidity and disease severity. Considering the
likelihood of a correlation between patient age and disease
status, we tested and found a significant interaction be-
tween these variables. All interaction terms were incorpo-
rated into the final adjusted model as shown in Table 7.
There was a significant effect of time, with a steady in-
crease in the odds of health centres being within the top
quartile of Type 2 diabetes service delivery from baseline
to 2012. Health centres had approximately three times
greater odds of top quartile performance in 2012 com-
pared to 2005/2006 (95% CI 2.37-3.53) (Table 7, Model
A). The effect of time diminished after adjusting for health
centre and patient level factors (Table 7, Models B and C).
The PCV in Model B (Table 7) shows that the addition
of health centre factors explained 37% of the variation
across jurisdictions and health centres. The longer the
duration of participation in the ABCD CQI program, thes by age group
Number of disease complications
None 1-2 >2 Total
n (%) n (%) n (%)
168 (94) 7 (4) 3 (2) 178
1693 (93) 110 (6) 27 (1) 1830
3680 (85) 449 (10) 152 (4) 4281
3559 (81) 602 (14) 224 (5) 4385
9100 (85) 1168 (11) 406 (4) 10674
Table 5 Duration of CQI participation by health centre characteristic
Completed Baseline only Completed 1–2 cycles Completed > =3 cycles Total
n (%) n (%) n (%) n (%)
Remoteness Non-Remote 6 (19) 16 (29) 5 (11) 27 (20)
Remote 5 (16) 5 (9) 6 (13) 16 (12)
Very Remote 21 (66) 34 (62) 34 (76) 89 (67)
Total 32 (100) 55 (100) 45 (100) 132 (100)
Governance Community-controlled 7 (22) 7 (13) 21 (47) 35 (27)
Government 25 (78) 48 (87) 24 (53) 97 (73)
Total 32 (100) 55 (100) 45 (100) 132 (100)
Population <=500 16 (50) 28 (51) 14 (31) 58 (44)
501-999 2 (6) 11 (20) 13 (29) 26 (20)
> = 1000 14 (44) 16 (29) 18 (40) 48 (36)
Total 32 (100) 55 (100) 45 (100) 132 (100)
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vice delivery, particularly for health centres in remote
and very remote locations (remote:1–2 cycles OR = 2.92,
95% CI 1.36-6.24; ≥3 cycles OR = 3.14, 95% CI 1.37-7.18;
very remote: 1–2 cycles OR = 4.03, 95% CI 2.27-7.16;
≥3 cycles OR = 4.72, 95% CI 2.47-9.02). Health centres
with a higher proportion of patients that attended within
the previous six months also had better odds of being
within the top quartile (OR = 1.40; 95% CI 1.22-1.60).
The addition of patient level factors in Model C had a
modest effect, accounting for a further 1% of the variation
in service delivery across health centres and jurisdictions.
In most age groups, patients with co-morbidities and dis-
ease complications had greater odds of receiving higher
level care than those without these conditions.
The variation in the odds of top quartile delivery was
reduced between jurisdictions and health centres afterFigure 1 Type 2 diabetes service delivery over time. Mean percent Typ
(n = 132) and b) health centres that have participated in CQI for 3 or moreaccounting for health centre and patient variables from
MORSTATE-HC = 4.68 (Model A; Table 7) to MORSTATE-HC =
3.38 (Model C; Table 7). Changes in predicted odds for
top quartile service delivery after adjusting for time and
health centre and patient factors are shown in Figures 2
and 3 respectively. The highest performing outlier after
adjusting for health centre and patient characteristics
(Figure 3b) is a centre from a non-remote area that had
completed one ABCD CQI Type 2 diabetes audit cycle
since it joined in 2010. This health centre is renowned for
its clinical leadership and model of care suited to the local
Aboriginal and Torres Strait Islander population; factors
which are not accounted for in this current analysis.
Discussion
There were improvements over time in the level of Type 2
diabetes care across the diverse range of Aboriginal ande 2 diabetes service delivery by a) all health centres over audit years
years (n = 45) over successive audit cycles.
Table 6 Unadjusted multilevel regression analysis of health centre and patient level factors on delivery of guideline
scheduled Type 2 diabetes services (n = 10674 clients; 132 health centres)
Outcome is >76% service delivery Unadjusted
Predictors OR 95% CI p-values
Audit Year 2005/6 1.00 (reference)
2007 1.62 (1.32-1.98) <0.0001
2008 1.90 (1.57-2.32) <0.0001
2009 2.41 (1.99-2.93) <0.0001
2010 2.23 (1.80-2.76) <0.0001
2011 2.40 (1.97-2.93) <0.0001
2012 2.89 (2.37-3.53) <0.0001
Health Centre Characteristics
Location Non-remote 1.00 (reference)
Remote 2.55 (1.22-5.35) 0.013
Very Remote 4.57 (2.61-8.01) <0.0001
Governance Government operated 1.00 (reference)
Community-controlled 1.09 (0.64-1.87) 0.75
Service population ≤500 1.00 (reference)
>500- < 1000 1.38 (0.81-2.35) 0.24
≥1000 0.80 (0.49-1.30) 0.37
Patient attendance in last 6 months Lower attendance 1.00 (reference)
Higher attendance 1.57 (1.38-1.79) <0.0001
Duration of CQI participation Baseline 1.00 (reference)
1-2 cycles 1.86 (1.66-2.09) <0.0001
≥3 cycles 2.33 (2.03-2.68) <0.0001
Patient Characteristics
Sex Male 1.00 (reference)
Female 1.06 (0.96-1.16) 0.24
Age (years) ≥15- < 25 1.00 (reference)
≥25- < 40 1.60 (1.09-2.35) 0.017
≥40- < 55 2.16 (1.48-3.15) <0.0001
≥55 2.61 (1.79-3.81) <0.0001
Indigenous status Non-Indigenous 1.00 (reference)
Indigenous 1.03 (0.84-1.26) 0.80
Comorbidity One condition 1.00 (reference)
≥2 conditions 1.54 (1.38-1.71) <0.0001
Complications None 1.00 (reference)
1-2 complications 1.44 (1.27-1.64) <0.0001
>2 complications 1.77 (1.20-2.60) 0.004
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in a wide-scale CQI project. The main factors associated
with improvement were duration of participation in CQI,
the location of the health centre, regularity of patient at-
tendance and patient age, co-morbidity and disease severity.
A significant proportion of the variation across juris-
dictions and centres was explained by health centre fac-
tors within the model (37%). There is an independentrelationship between the duration of participation in
ABCD CQI and improved documented adherence to
best practice guidelines, with centres that participated
for 3 or more cycles having between 1.5 to 5 times the
odds of top quartile service delivery to patients depending
on location (Model C; Table 7). This finding indicates that
health centres in varying geographical contexts appear to
obtain benefits from sustained CQI participation. Long
Table 7 Adjusted multilevel regression analysis of health centre and patient level factors on delivery of guideline
scheduled Type 2 diabetes services (n = 10,674 clients; 132 health centres)
Outcome is >76% service delivery Empty Model A Model B Model C
Predictors Fixed effects OR 95% CI OR 95% CI OR 95% CI
Audit Year 2005/2006 1.00 (reference) 1.00 (reference) 1.00 (reference)
2007 1.62 (1.32-1.98)*** 1.14 (0.91-1.44) 1.20 (0.95-1.51)
2008 1.90 (1.57-2.32)*** 1.21 (0.95-1.54) 1.30 (1.02-1.67)*
2009 2.41 (1.99-2.93)*** 1.35 (1.03-1.77)* 1.40 (1.07-1.83)*
2010 2.23 (1.80-2.76)*** 1.16 (0.86-1.57) 1.17 (0.86-1.59)
2011 2.40 (1.97-2.93)*** 1.25 (0.92-1.71) 1.24 (0.91-1.69)
2012 2.89 (2.37-3.53)*** 1.18 (0.82-1.68) 1.17 (0.82-1.67)
Health Centre Characteristics
Location X duration of CQI participation
Non-remote: Baseline 1.00 (reference) 1.00 (reference)
1-2 cycles 1.53 (1.10-2.11)* 1.47 (1.06-2.04)*
≥3 cycles 1.62 (1.02-2.55)* 1.55 (0.98-2.45)
Remote: Baseline 1.00 (reference) 1.00 (reference)
1-2 cycles 2.92 (1.36-6.24)** 2.91 (1.36-6.22)**
≥3 cycles 3.14 (1.37-7.18)** 3.29 (1.44-7.54)**
Very Remote: Baseline 1.00 (reference) 1.00 (reference)
1-2 cycles 4.03 (2.27-7.16)*** 4.31 (2.43-7.67)***
≥3 cycles 4.72 (2.47-9.02)*** 5.05 (2.63-9.67)***
Patient attendance in last 6 months Lower attendance 1.00 (reference) 1.00 (reference)
Higher attendance 1.40 (1.22-1.60)*** 1.40 (1.22-1.61)***
Patient Characteristics (Age X disease status)
≥15- < 25 years: Comorbidity One condition 1.00 (reference)
2 or more conditions 1.83 (0.85-3.94)
≥15- < 25 years: Complications None 1.00 (reference)
1-2 complications 0.87 (0.13-5.68)
>2 complications 5.82 (0.45-74.5)
≥25- < 40 years: Comorbidity One condition 1.00 (reference)
2 or more conditions 1.38 (1.10-1.73)**
≥25- < 40 years: Complications None 1.00 (reference)
1-2 complications 2.40 (1.53-3.77)***
>2 complications 1.73 (0.72-4.13)
≥40- < 55 years: Comorbidity One condition 1.00 (reference)
2 or more conditions 1.43 (1.20-1.69)***
≥40- < 55 years: Complications None 1.00 (reference)
1-2 complications 1.32 (1.05-1.65)*
>2 complications 1.17 (0.80-1.70)
≥55 years: Comorbidity One condition 1.00 (reference)
2 or more conditions 1.26 (1.05-1.52)*
≥55 years: Complications None 1.00 (reference)
1-2 complications 1.29 (1.05-1.58)*
>2 complications 1.45 (1.04-2.01)*
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Table 7 Adjusted multilevel regression analysis of health centre and patient level factors on delivery of guideline
scheduled Type 2 diabetes services (n = 10,674 clients; 132 health centres) (Continued)
Random effects (intercepts)
State (variance (SE)) 1.41 (0.99) 0.72 (0.53) 0.69 (0.51)
MORSTATE 3.10 2.24 2.21
PCV (% explained variance) 49% 51%
Health Centre (variance (SE)) 1.21 (0.19) 0.93 (0.15) 0.94 (0.15)
MORHC 2.86 2.51 2.52
PCV (% explained variance) 23% 23%
State & Health Centre (variance) 2.62 1.65 1.63
MORSTATE-HC 4.68 3.41 3.38
PCV (% explained variance) 37% 38%
Patient (variance (SE)) 0.13 (0.072) 0.07 (0.03) 0.02 (0.012)
PCV (% explained variance) 44% 81%
*p < 0.05; **p < 0.01; ***p < 0.0001.
MOR (Median odds ratio): odds of receiving ‘top quartile service delivery’ if a patient was to change health centre or jurisdiction [17].
PCV (Proportional change in variance): percent variation explained in odds for better health care delivery by introduction of health centre or patient level factors [16].
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provements in health centres at the lower range of per-
formance, with an increase in the lowest levels of
adherence to best practice guidelines from less than 20%
to approximately 40% over three audit cycles (Figure 1b).
Health centres located in very remote (ASGC-RA 5)
and remote areas (ASGC-RA 4) had increased odds of
greater improvement in care processes over audit cycles
compared to non-remote health centres. The ASGC-RA
classification system is based on physical distance of the
community to the nearest urban area and reflects access
to goods and services [18]. The greater odds of a higher
level of service delivery in these areas may reflect less
complex service environments where the centre may be
the single primary health care provider and some dis-
tance away from other providers. The availability ofFigure 2 Variation in adherence to guidelines on best practice Type 2
a) jurisdictions and b) health centres according to their average delivery of
predicted from the regression Model A (adjusting for audit year only). Uncemultiple service providers in non-remote locations pro-
vides a challenge for primary health care centres in co-
ordinating and monitoring comprehensive delivery of
care to patients with chronic disease. Yet, the quality of
care shown by remote health centres has occurred in
service environments characterised by high staff turn-
over, high use of locums and limited access to specialist
services. Higher levels of service delivery in these areas
may be due to the implementation of specific models of
primary health care delivery (for example, hub and spoke
and outreach services) designed to overcome barriers of
remote geography, dispersed populations and to improve
coordination of care [19]. CQI may have contributed in
part to the development of these models of care as indi-
cated in a recent evaluation of the CQI Strategy in the
Northern Territory that suggested CQI processes led todiabetes service delivery before adjustment. Ranking of
Type 2 diabetes services relative to the overall average delivery as
rtainty around this estimate is illustrated by 95% confidence intervals.
Figure 3 Variation in adherence to guidelines on best practice Type 2 diabetes service delivery after adjustment. Ranking of
a) jurisdictions and b) health centres according to their average delivery of Type 2 diabetes services relative to the overall average delivery as
predicted from the regression Model C (adjusting for health centre and patient level factors). Uncertainty around this estimate is illustrated by
95% confidence intervals.
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crease in service delivery outputs [20].
Best practice Type 2 diabetes care dictates that pa-
tients receive certain services at regular intervals. It is
unsurprising that health centres with a higher percent-
age of patients (≥3%) not attending in the previous six
months had lower odds of providing best practice care.
While non-remote health centres had on average 25%
clients not attending in the previous six months compared
to 11% and 5% of patients in remote and very remote
areas respectively (Table 3), there was no significant statis-
tical interaction between regularity of patient attendance
and remoteness of health centres with respect to delivery
of Type 2 diabetes care.
The addition of patient-level characteristics into the
model explained only a small component of the variation
between health centres and jurisdictions (1%). There was
an increasing trend of co-morbidity and disease severity
with age (Table 4) and those patients who were older,
had co-morbidities and/or complications were more
likely to have greater odds of receiving top quartile ser-
vice delivery. Within most age groups, patients with co-
morbidities and complications had greater odds of re-
ceiving more services compared to those without. This
finding may reflect more opportunities for providing
care or greater emphasis on managing high risk patients.
Higher levels of care for high need patients along with
general improvements in overall standards of care
should contribute to a reduction in the Type 2 diabetes
disease burden on health care systems and improved
population health outcomes.
There was a consistent trend of increasing odds of top
quartile service delivery over audit years compared to
the baseline year 2005/6 apart from a flattening outperiod in 2010 (Table 7, Model A). The 2010–2011 period
marked a new expansion phase for the ABCD project with
new centres joining and the commencement of a nation-
wide CQI service support agency (One21seventy) designed
to assist with implementation of the ABCD CQI tools and
processes. Also in 2010, two jurisdictions implemented a
network of regional CQI facilitators to support health cen-
tres with their CQI activities. The number of health cen-
tres participating and the number of audits undertaken,
including Type 2 diabetes, increased substantially from
2011 once the new support infrastructure was in place.
Jurisdictional differences in the odds of health centres be-
ing within the top quartile of service delivery may be at-
tributed to the variable state-wide level support systems as
well as the staggered commencement of participation in
the ABCD project. Employment of regional positions that
supported collaboration and information exchange across
health centres was a key explanatory factor for improved
performance at health centre level over time [21]. The top
two ranked jurisdictions with respect to odds of top quar-
tile delivery, before and after adjusting for health centre
and patient factors (Figures 2a and 3a), are those that par-
ticipated for more years in ABCD and/or have a regional
CQI facilitator network. Similar factors have been attrib-
uted to the success of a long term diabetes quality of care
project in a remote community of Western Australia [22].
Learnings from jurisdictions where there is well estab-
lished macro-level CQI infrastructure can support the de-
velopment of similar structures in other jurisdictions [23].
The investigation of patient, health centre and jurisdic-
tional level factors that underlie variation in adherence
to best practice Type 2 diabetes care has been made
possible by the availability of the extensive CQI audit
dataset from health centres participating in the ABCD
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participation in this study by health centres, however,
limits the generalisability of study findings. In addition,
as data are collected from client records, service delivery
may be underestimated due to poor documentation. Al-
though a strength of this study design is the ability to
correct for a range of known confounding factors, it is
also recognised that the associations identified in this
study, may be due, in part, to other unmeasured con-
founders. For example, there may be factors associated
with longer term participation in CQI that may be re-
sponsible for the demonstrated improvements in adher-
ence to best practice guidelines, such as well-functioning
community health centres with good leadership and
workforce stability that are both more likely to maintain
CQI processes, and to achieve better results in diabetes
management. The exemplary centre in Figure 3b is a
case in point where their level of service delivery is
amongst the best despite relatively limited participation
in ABCD CQI to date. As mentioned, the health centre
is renowned for its clinical leadership and model of care
built around its own local CQI processes. To elucidate
other potentially confounding factors enabling quality
improvement, further quantitative and qualitative studies
are planned to examine micro-, meso- and macro-level
factors that have facilitated sustained improvement in
high performing health centres [24]. It is important to
note that it is through participation in the CQI initiative
that data are available for the sort of analysis presented
in this study. There are currently no other sources of
comparable data in Australian primary care that would
enable establishment of a comparison group not partici-
pating in the CQI program.Conclusions
The findings of this study suggest that at the health centre
level, the quality of Type 2 diabetes care for Aboriginal
and Torres Strait Islander communities is associated with
long term commitment to a CQI program. Sustained par-
ticipation has particularly benefitted remote and very re-
mote health centres and health centres performing at the
lower range of service provision. Our findings suggest that
improving regularity of patient attendance, better coordin-
ation and documentation of care within non-remote mul-
tiple service provider environments and sharing lessons
from the successes of care coordination in remote areas
has the potential to improve care delivery across the
spectrum of health centres. Further understanding of sys-
tem wide factors that underpin jurisdictional variation in
delivery of care will assist health managers and policy
makers to understand and develop macro-level strategies
to improve quality of Type 2 diabetes care in Aboriginal
and Torres Strait Islander communities.Abbreviations
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